- Entry
- $3.39
- Now
- $2.78 -18.0%
- Target
- —
- Score
- —
Initial disclaimer, do your own due diligence on any statements made in this post. I am an investor in this company. Fortress Biotech is basically a holding company, and leverages their capital to develop drugs for sale directly or licensing for royalty payments. They own a big chunk of Journey Medical, ticker DERM, that sells dermatology products, with an oral doxycycline approved. Journey is generating revenue and projected to reach profitability this year. They own approximately 75% of Cyprium Therapeutics. …
— ORIGINAL POST ·
FBIO Positioned for Growth?
· r/pennystocks
· Jul 28, 2026